Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Upendra Man Shrestha"'
Autor:
Samir Koirala, Buddha Basnyat, Amit Arjyal, Olita Shilpakar, Kabina Shrestha, Rishav Shrestha, Upendra Man Shrestha, Krishna Agrawal, Kanika Deshpande Koirala, Sudeep Dhoj Thapa, Abhilasha Karkey, Sabina Dongol, Abhishek Giri, Mila Shakya, Kamal Raj Pathak, James Campbell, Stephen Baker, Jeremy Farrar, Marcel Wolbers, Christiane Dolecek
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 7, Iss 10, p e2523 (2013)
Fluoroquinolones are the most commonly used group of antimicrobials for the treatment of enteric fever, but no direct comparison between two fluoroquinolones has been performed in a large randomised trial. An open-label randomized trial was conducted
Externí odkaz:
https://doaj.org/article/802a95119e9e4124aefb119e76b5346a
Autor:
Kabina Shrestha, Christiane Dolecek, Mila Shakya, James Campbell, Jeremy Farrar, Amit Arjyal, Krishna Agrawal, Stephen Baker, Kanika Deshpande Koirala, Olita Shilpakar, Upendra Man Shrestha, Sabina Dongol, Sudeep Dhoj Thapa, Samir Koirala, Buddha Basnyat, Abhilasha Karkey, Kamal Raj Pathak, Marcel Wolbers, Rishav Shrestha, Abhishek Giri
Publikováno v:
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, Vol 7, Iss 10, p e2523 (2013)
PLoS Neglected Tropical Diseases, Vol 7, Iss 10, p e2523 (2013)
Background Fluoroquinolones are the most commonly used group of antimicrobials for the treatment of enteric fever, but no direct comparison between two fluoroquinolones has been performed in a large randomised trial. An open-label randomized trial wa
Autor:
Sabina Dongol, Duy Pham Thanh, Jeremy Farrar, Amit Arjyal, Stephen Baker, Upendra Man Shrestha, Kanika Deshpande Koirala, Sudeep Dhoj Thapa, Abhilasha Karkey, Buddha Basnyat
Publikováno v:
Antimicrobial Agents and Chemotherapy. 56:2761-2762
As a consequence of multidrug resistance, clinicians are highly dependent on fluoroquinolones for treating the serious systemic infection typhoid fever. While reduced susceptibility to fluoroquinolones, which lessens clinical efficacy, is becoming ub